Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc
The coagulation protease activated protein C (aPC) confers cytoprotective effects in various in vitro and in vivo disease models, including diabetic nephropathy. The nephroprotective effect may be related to antioxidant effects of aPC. However, the mechanism through which aPC may convey these antiox...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
January 8, 2013
|
| In: |
Proceedings of the National Academy of Sciences of the United States of America
Year: 2013, Volume: 110, Issue: 2, Pages: 648-653 |
| ISSN: | 1091-6490 |
| DOI: | 10.1073/pnas.1218667110 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1073/pnas.1218667110 Verlag, Volltext: https://www.pnas.org/content/110/2/648 |
| Author Notes: | Fabian Bock, Khurrum Shahzad, Hongjie Wang, Stoyan Stoyanov, Juliane Wolter, Wei Dong, Pier Giuseppe Pelicci, Muhammed Kashif, Satish Ranjan, Simone Schmidt, Robert Ritzel, Vedat Schwenger, Klaus G. Reymann, Charles T. Esmon, Thati Madhusudhan, Peter P. Nawroth, and Berend Isermann |